Could This New Skin-Like Sensor Stop Sepsis in Its Tracks?

The Rise of Wearable Health Technology

Wearable health devices have reshaped how we monitor wellness, evolving from simple pedometers in the early 2000s that counted steps to today’s advanced biosensors. By the 2010s, Fitbit introduced heart rate and sleep tracking, while modern devices like the Apple Watch and Whoop strap measure electrocardiograms (ECG) and blood oxygen levels, syncing data to smartphones for instant feedback. Yet, for the 49 million people affected by sepsis annually, these devices often prove ineffective. Consumer wearables excel at basic metrics but struggle with continuous, multimodal monitoring (tracking heart rate, temperature, and biochemical markers simultaneously) or real-time processing. Apple Watch offers ECG but lacks biochemical sensing; Fitbit’s accuracy wanes during intense activity; Whoop requires subscriptions, limiting access. Additionally, conventional wearables rely on rigid electronics and external computing resources, creating mechanical mismatches with skin, compromising signal quality, and raising security concerns. These gaps leave patients vulnerable when hours matter for life-threatening conditions like sepsis, where a 30% mortality rate looms without early detection. Recent research by Choi and colleagues has introduced a breakthrough approach called CSPINS (Chip-less Skin-conformable Printed Intelligent Neuromorphic System). That being a flexible, standalone system that replicates brain-like processing to simultaneously monitor, analyze, and make diagnostic decisions in real-time, addressing these critical limitations through an innovative wearable platform designed specifically for sepsis monitoring.

The global wearable medical devices market was valued at around $91 billion in 2024 and is projected to grow to over $324 billion by 2032, indicating a massive shift towards personalized health monitoring. CSPINS is poised to carve out a significant niche within this rapidly expanding sector by addressing critical unmet needs.

While these consumer devices have democratized basic health monitoring, they fall short when lives hang in the balance. Consider sepsis, a condition where every minute counts, yet current wearables remain silent as the body’s immune system spirals out of control. To understand why CSPINS represents such a crucial leap forward, we must first grasp the deadly urgency of sepsis detection.

Understanding Sepsis: A Silent Threat

Sepsis arises when an infection, often bacterial, triggers a dangerous immune response, leading to organ dysfunction. Symptoms like fever, rapid heart rate (>90 beats per minute), fast breathing, or confusion can be subtle, easily confused with less severe illnesses, making early diagnosis difficult. With 49 million cases and 11 million deaths globally each year (Source: WHO), sepsis carries a 30% mortality rate if not caught early. In the U.S., it drives over $62 billion in healthcare costs annually due to intensive care and prolonged hospital stays (Source: AAMC).

For patients, the difference between detection and disaster often comes down to hours, yet current diagnostics (i.e., blood tests and hospital monitors) require clinical settings, delaying critical intervention for those at home or in remote areas. This delay disproportionately affects certain communities. For instance, Black individuals have nearly twice the incidence of sepsis as White individuals. Historically, Black and Hispanic patients have also experienced higher rates of morbidity and mortality from sepsis compared to White patients. Studies have further shown that Black patients may be 43% less likely to receive timely antibiotic administration within 1 hour of sepsis code activation compared to White patients. These disparities underscore the urgent need for accessible and equitable diagnostic tools (Sources: Sepsis.org; PubMed; Dominican Scholar).

The window for effective sepsis treatment is measured in hours, not days. This race against time has driven researchers to reimagine health monitoring entirely, leading to systems like CSPINS that can detect sepsis signals in real time, wherever patients are. But how exactly does this technology work at the physiological level?

Real-Time Heart Rate and Signal Processing: A Step Toward Sepsis Detection

For sepsis patients worldwide, a rapid heart rate is a critical warning sign. The CSPINS system introduces a wearable analog processor that captures cardiovascular signals without bulky, resource intensive circuits. Using a flexible, 3D-printed conductive sponge made from multi-walled carbon nanotubes and PDMS, it detects subtle skin movements from blood vessel pulses, converting resistance changes into voltage pulses amplified into synaptic currents. This setup translates heartbeat frequencies (55–160 beats per minute) with accuracy comparable to commercial HR monitors during rest and exercise.

But accuracy is only half the battle. Speed matters just as much. Operating on a 10-second cycle, it updates signals instantly, ideal for dynamic conditions like physical activity. In sepsis, where a heart rate above 90 beats per minute signals danger, this real-time monitoring can mean the difference between life and death.

CSPINS also uses synaptic nodes, printed on flexible polyimide films, with memristors that switch resistance when currents cross thresholds. This allows classification of heart rate alongside lactate and core body temperature (CBT), distinguishing sepsis from conditions like systemic inflammatory response syndrome (SIRS). In a study of 10 human subjects, CSPINS achieved 84.4% accuracy in diagnosing sepsis, using just 37.6 μW for synaptic operations, ensuring long-term wear without battery drain. This efficiency is crucial for continuous monitoring, keeping patients safe when every hour counts.

For patients facing sepsis, this real-time detection capability fundamentally changes the trajectory of care. Early identification doesn’t just improve individual outcomes—it transforms the entire healthcare experience. Patients avoid the cascading complications that lead to organ failure, reducing intensive care stays from weeks to days. For healthcare systems already strained by sepsis-related costs exceeding $62 billion annually in the U.S. alone, early detection means fewer emergency interventions, shorter hospital stays, and dramatically reduced treatment expenses. More importantly, it gives families hope instead of devastating last-minute diagnoses, turning potential tragedies into manageable medical events.

These technical achievements sound impressive on paper, but the real test lies in how CSPINS performs against the gold standard of hospital-based monitoring. Can a flexible, printed device really compete with established clinical protocols?

CSPINS vs. Current Sepsis Detection Methods

Hospital-based sepsis detection relies on bedside monitors for vital signs and lab tests like blood cultures or lactate measurements, which are precise but confined to clinical settings. These methods require invasive procedures, trained staff, and often hours for results, delaying care for patients outside hospitals. CSPINS, a wearable, chip-less system, monitors heart rate, CBT, and lactate non-invasively, offering portability and comfort. Its flexible, printed sensors fit snugly against skin, enabling continuous use without irritation, unlike bulky hospital monitors or chest straps that can discomfort patients. By processing data on-device with neuromorphic circuits, CSPINS ensures privacy, unlike consumer devices like Fitbit, which may share data with third parties.

However, CSPINS’s small initial study (10 subjects) requires larger trials for validation. Scaling production to maintain quality and affordability, plus securing regulatory approval from bodies like the FDA, are critical steps to ensure clinical reliability. These factors must be addressed to make CSPINS a trusted tool for sepsis detection.

How Does CSPINS Compare?

AspectHospital-Based MethodsCSPINS
SettingClinical onlyWearable, home or hospital
MonitoringIntermittent, invasiveContinuous, non-invasive
Data ProcessingLab-based, delayedReal-time, on-device
ComfortBulky, uncomfortableFlexible, skin-conformal
PrivacyControlled environmentOn-device, encrypted processing

Understanding CSPINS’s advantages is one thing—actually building such a sophisticated yet wearable system is another task entirely. The challenge lies in making hospital-grade precision feel as comfortable as a Band-Aid. The advance lies not just in what it can do, but in how it’s made to be both medically precise and comfortably wearable.

Crafting a Wearable System for Sepsis Monitoring

For millions at risk of sepsis, early detection hinges on precise, reliable technology. CSPINS is built using scalable inkjet printing on flexible polyimide (PI) and polyethylene terephthalate (PET) substrates, making it lightweight and skin-conformal. Gold and silver inks form electrodes, while single-walled carbon nanotubes (SWCNTs), poly(3-hexylthiophene) (P3HT), and Nafion create synaptic sensors and nodes. Artificial synapses, printed with SWCNT and P3HT layers and an ion-gel dielectric cured under UV light, ensure accurate signal transduction (Choi et al., 2025). Biochemical sensors for lactate and glucose, vital sepsis markers, use Prussian blue or platinum nanoparticles with enzyme cocktails to convert molecular signals into currents. Amplifiers and synaptic nodes, printed with multi-walled carbon nanotubes (MWCNTs) and cross-linked poly(4-vinyl phenol) dielectrics, process heart rate and CBT efficiently.

Safety was verified through cytocompatibility tests with human dermal fibroblast cells, showing no adverse effects via LIVE/DEAD and PrestoBlue assays. Human testing, under a Caltech Institutional Review Board protocol, involved 10 participants with varied health statuses. CSPINS processed simulated biomarker data (heart rate, CBT, lactate) through its neural network, achieving 84.4% accuracy in identifying sepsis by flagging elevated heart rate (>90 BPM), CBT (>37.5°C), and lactate (>2 mM). Its low power consumption (37.6 μW) supports continuous use, critical when hours matter for sepsis patients.

With the technical foundation established and safety confirmed, the question becomes: how would CSPINS actually improve patient care in the real world? Consider these scenarios where early sepsis detection could mean the difference between life and death:

Real-Life Applications: CSPINS in Action

For a patient recovering at home after surgery, CSPINS could monitor heart rate and lactate levels, detecting early sepsis signs like a spike above 90 BPM or 2 mM lactate, alerting clinicians via a smartphone app to prevent rehospitalization. In a nursing facility, an elderly person with a chronic infection could wear CSPINS to track CBT and heart rate, ensuring prompt intervention if sepsis develops, reducing the 30% mortality risk. Athletes, prone to inflammation from overtraining, could use CSPINS to monitor lactate and heart rate, optimizing recovery and avoiding health complications. These scenarios show how CSPINS empowers patients and providers with real-time insights, saving lives when every hour counts.

Integration with electronic health records (EHRs) enhances CSPINS’s impact. Data on heart rate, CBT, and lactate can be securely transmitted to EHR systems, allowing clinicians to monitor trends and receive alerts for abnormal readings (e.g., lactate >2 mM). Encryption ensures privacy, addressing concerns with consumer devices like Fitbit. This connectivity supports proactive care, especially for high-risk patients, making CSPINS a practical tool for modern healthcare.

These real-world applications demonstrate CSPINS’s immediate potential, but they also reveal a larger opportunity. If a wearable device can detect sepsis this effectively, what other life-threatening conditions might yield to similar approaches?

Advancing Sepsis Diagnosis and Beyond

The goal is clear which is to develop a wearable system that integrates physiological and biochemical signals for rapid, accurate detection of conditions like sepsis. With sepsis affecting millions and carrying a 30% mortality rate, urgent diagnosis is essential to improve outcomes. By analyzing patterns in multimodal data (heart rate, CBT, lactate, and glucose) CSPINS addresses a core question which is “How can wearables deliver real-time, life-saving insights?” In the near term, it could enhance diagnostic tools, enabling faster sepsis identification. Long-term, incorporating adaptive thresholds and motion recognition could improve precision, making CSPINS a versatile platform for conditions like heart failure or diabetes. The real question isn’t whether the technology works but whether patients will actually use it consistently when their lives depend on it.

A New Horizon for Health Monitoring

The path forward is to turn encouraging results into a widely accessible medical tool. CSPINS marks a significant advance in wearable health technology, particularly for sepsis, where hours matter. Its flexible, printed sensors and neuromorphic processing monitor heart rate, CBT, and biochemical markers in real time with 84.4% accuracy, offering portability, comfort, and privacy over hospital-based systems. While larger trials and regulatory approvals are needed, its potential to save lives through early detection is undeniable. By integrating with EHRs and supporting diverse use cases (from post-surgical recovery to elderly care) CSPINS sets a new standard for accessible, efficient healthcare solutions, proving that early detection truly saves lives.

Citation: Choi, Y., Jin, P., Lee, S., et al. (2025). All-printed chip-less wearable neuromorphic system for multimodal physicochemical health monitoring. Nature Communications, 16(5689). https://doi.org/10.1038/s41467-025-45689-x

Related Articles

PHP Code Snippets Powered By : XYZScripts.com
★

Track This Company

Create a free account to add companies to your watchlist and get notified when patents, funding, or key developments change.